These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 25462263)

  • 1. Phenyl acetate derivatives, fluorine-substituted on the phenyl group, as rapid recovery hypnotic agents with reflex depression.
    Zhang H; Xu X; Chen Y; Qiu Y; Liu X; Liu BF; Zhang G
    Eur J Med Chem; 2015 Jan; 89():524-39. PubMed ID: 25462263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of fluorine-substituted phenyl acetate derivatives as ultra-short recovery sedative/hypnotic agents.
    Zhang H; Xu X; Chen Y; Qiu Y; Liu X; Liu BF; Zhang G
    PLoS One; 2014; 9(5):e96518. PubMed ID: 24796695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and evaluation of phenylpiperazine-phenylacetate derivatives as rapid recovery hypnotic agents.
    Qi Z; Li Z; Zhu M; Zhang X; Zhang G; Zhuang T; Chen Y; Huang L
    Bioorg Med Chem Lett; 2022 Feb; 57():128497. PubMed ID: 34896213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABAA receptor pharmacology of fluorinated derivatives of the novel sedative-hypnotic pyrazolopyrimidine indiplon.
    Wegner F; Deuther-Conrad W; Scheunemann M; Brust P; Fischer S; Hiller A; Diekers M; Strecker K; Wohlfarth K; Allgaier C; Steinbach J; Hoepping A
    Eur J Pharmacol; 2008 Feb; 580(1-2):1-11. PubMed ID: 18035350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro pharmacological studies of methoxycarbonyl-carboetomidate.
    Pejo E; Cotten JF; Kelly EW; Le Ge R; Cuny GD; Laha JK; Liu J; Lin XJ; Raines DE
    Anesth Analg; 2012 Aug; 115(2):297-304. PubMed ID: 21965364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological activity of acyl substituted 3-amino-5-methyl-1,4,5,7-tetrahydropyrazolo[3,4-b]pyridin-6-ones as potential hypnotic drugs.
    Falcó JL; Lloveras M; Buira I; Teixidó J; Borrell JI; Méndez E; Terencio J; Palomer A; Guglietta A
    Eur J Med Chem; 2005 Nov; 40(11):1179-87. PubMed ID: 16095764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and steroidogenic pharmacology of phenyl ring substituted etomidate analogs in rats.
    McGrath M; Hofmann A; Raines DE
    BMC Pharmacol Toxicol; 2019 Aug; 20(1):48. PubMed ID: 31383012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of fluorine substituted pyrazolopyrimidines as potential leads for the development of PET-imaging agents for the GABAA receptors.
    Hoepping A; Diekers M; Deuther-Conrad W; Scheunemann M; Fischer S; Hiller A; Wegner F; Steinbach J; Brust P
    Bioorg Med Chem; 2008 Feb; 16(3):1184-94. PubMed ID: 18023192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and pharmacological evaluation of new neuroactive pyrazolo[3,4-b]pyrrolo[3,4-d]pyridine derivatives with in vivo hypnotic and analgesic profile.
    Menegatti R; Silva GM; Zapata-Sudo G; Raimundo JM; Sudo RT; Barreiro EJ; Fraga CA
    Bioorg Med Chem; 2006 Feb; 14(3):632-40. PubMed ID: 16198114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous gamma-aminobutyric acid (GABA)(A) receptor active neurosteroids and the sedative/hypnotic action of gamma-hydroxybutyric acid (GHB): a study in GHB-S (sensitive) and GHB-R (resistant) rat lines.
    Barbaccia ML; Carai MA; Colombo G; Lobina C; Purdy RH; Gessa GL
    Neuropharmacology; 2005 Jul; 49(1):48-58. PubMed ID: 15992580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.
    Hu LY; Guo J; Magar SS; Fischer JB; Burke-Howie KJ; Durant GJ
    J Med Chem; 1997 Dec; 40(26):4281-9. PubMed ID: 9435897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoliquiritigenin, a chalcone compound, is a positive allosteric modulator of GABAA receptors and shows hypnotic effects.
    Cho S; Kim S; Jin Z; Yang H; Han D; Baek NI; Jo J; Cho CW; Park JH; Shimizu M; Jin YH
    Biochem Biophys Res Commun; 2011 Oct; 413(4):637-42. PubMed ID: 21945440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the Hypnotic Potency in Rats of the Novel Ketamine Ester Analogue SN 35210.
    Harvey M; Sleigh J; Voss L; Pruijn F; Jose J; Gamage S; Denny W
    Pharmacology; 2015; 96(5-6):226-32. PubMed ID: 26352278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased brain monoaminergic tone after the NMDA receptor GluN2A subunit gene knockout is responsible for resistance to the hypnotic effect of nitrous oxide.
    Petrenko AB; Yamakura T; Kohno T; Sakimura K; Baba H
    Eur J Pharmacol; 2013 Jan; 698(1-3):200-5. PubMed ID: 23123346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiating effect of glabridin on GABAA receptor-mediated responses in dorsal raphe neurons.
    Jin Z; Kim S; Cho S; Kim IH; Han D; Jin YH
    Planta Med; 2013 Oct; 79(15):1408-12. PubMed ID: 23975867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic intermittent exposure to ethanol during adolescence produces tolerance to the hypnotic effects of ethanol in male rats: a dose-dependent analysis.
    Matthews DB; Tinsley KL; Diaz-Granados JL; Tokunaga S; Silvers JM
    Alcohol; 2008 Dec; 42(8):617-21. PubMed ID: 19038695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of NMDA and GABAA pharmacological manipulations on ethanol sensitivity in immature and mature animals.
    Silveri MM; Spear LP
    Alcohol Clin Exp Res; 2002 Apr; 26(4):449-56. PubMed ID: 11981119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABA(A) receptor modulators from the Chinese herbal drug Junci Medulla--the pith of Juncus effusus.
    Singhuber J; Baburin I; Khom S; Zehl M; Urban E; Hering S; Kopp B
    Planta Med; 2012 Mar; 78(5):455-8. PubMed ID: 22271080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.
    Depoortere H; Zivkovic B; Lloyd KG; Sanger DJ; Perrault G; Langer SZ; Bartholini G
    J Pharmacol Exp Ther; 1986 May; 237(2):649-58. PubMed ID: 2871178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AZD-3043: a novel, metabolically labile sedative-hypnotic agent with rapid and predictable emergence from hypnosis.
    Egan TD; Obara S; Jenkins TE; Jaw-Tsai SS; Amagasu S; Cook DR; Steffensen SC; Beattie DT
    Anesthesiology; 2012 Jun; 116(6):1267-77. PubMed ID: 22531340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.